Flunitrazepam and driving ability. A critical analysis of relevant studies;Flunitrazepam und fahrtüchtigkeit: Eine kritische analyse relevanter studien

Fortschritte der Neurologie Psychiatrie

Volumn 72, Issue 9, 2004, Pages 503-515

  Kaufmann, Rainer Marco ^a   Frey, R ^a   Battista, H J ^b   Kasper, S ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Gerichtlich Beeideter S A C   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHETAMINE; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; DIAZEPAM; FLUNITRAZEPAM; FLURAZEPAM; HYPNOTIC AGENT; LORMETAZEPAM; LYSERGIDE; MIDAZOLAM; MORPHINE; NITRAZEPAM; PENTOBARBITAL; PLACEBO; QUAZEPAM; TEMAZEPAM; TRIAZOLAM; ZOLPIDEM; ZOPICLONE;

ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRIVING ABILITY; DRUG DOSE REGIMEN; DRUG EFFECT; FUNCTIONAL DISEASE; HUMAN; LABORATORY TEST; MEDICAL LITERATURE; MEDLINE; METHODOLOGY; PARAMETER; PSYCHOMOTOR ACTIVITY; RISK ASSESSMENT; STATISTICAL ANALYSIS; TASK PERFORMANCE; TECHNIQUE;

ANTI-ANXIETY AGENTS; AUTOMOBILE DRIVING; FLUNITRAZEPAM; HUMANS; PSYCHOMOTOR PERFORMANCE;

EID: 4544225369     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-812459     Document Type: Article

References (81)

1. Woods JH, Winger G. Abuse liability of Flunitrazepam. J Clin Psychopharmacol 1997; 17 (Suppl. 2): 1S-57S
2. Busto U, Bendayan R, Sellers EM. Clinical pharmacokinetics of non-opiate abused drugs. Clin Pharmacokinet 1989; 16: 1-26
3. Jochemsen R, Breimer DD. Pharmacokinetics of benzodiazepines: metabolic pathways and plasma level profiles. Curr Med Res Opin 1984; 8: 60-79
4. Owen RT, Tyrer P. Benzodiazepine dependence: a review of the evidence. Drugs 1983; 25: 385-398
5. Farré M, Terán MT, Camí J. A comparison of the acute behavioural effects of flunitrazepam and triazolam in healthy volunteers. Psychopharmacology 1996; 125: 1-12
6. Farré M, Terán MT, Roset PN, Mas M, Torrens M, Camí J. Abuse liability of flunitrazepam among methadone-maintained patients. Psychopharmacology 1998; 140: 486-495
7. Keup W. Flunitrazepam (Rohypnol) - führend beim Missbrauch unter den Benzodiazepin-Derivaten. Sucht 1992; 38: 3-6
8. Barnas C, Rossmann M, Rössler H, Reimer Y, Fleischhacker WW. Benzodiazepines and other psychotropic drugs abused by patients in a methadone maintenance program: familiarity and preference. J Clin Psychopharmacol 1992; 12: 397-402
9. Navaratnam V, Foong K. Adjunctive drug use among Opiate addicts. Curr Med Res Opin 1990; 11: 611-619
10. San L, Tato J, Torrens M, Castillo C, Farré M, Cami J. Flunitrazepam consumption among Heroin addicts admitted for inpatient detoxification. Drug Alcohol Depend 1993; 32: 281-286
11. Calhoum SR, Wesson DR, Galloway GP, Smith DE. Abuse of Flunitrazepam (Rohypnol) and other benzodiazepines in Austin and SouthTexas. J Psychoact Drugs 1996; 28: 183-189
12. Krüger HP, Schulz E, Magerl H. Medikamenten- und Drogennachweis bei verkehrsunauffälligen Fahrern, Roadside Survey. Berichte der Bundesanstalt für Straßenwesen, Mensch und Sicherheit. 1996: Heft M 60
13. Augsburger M, Rivier L. Drugs and alcohol among suspected impaired drivers in Canton de Vaud (Switzerland). Forensic Sci Int 1997; 85: 95-104
14. Lillesunde P, Korte T, Michelson L, Portman M, Pikkarainen J. Drugs usage of drivers suspected of driving under the influence of alcohol and/or drugs. A study of one week's samples in 1979 and 1993 in Finland. Forensic Sci Int 1996; 77: 119-129
15. Skurtveit S, Christophersen AS, Morland J. Female drivers suspected for drunken or drugged driving. Forensic Sci Int 1995; 75: 139-148
16. Barbone F, McMahon AD, Davey PG, Morris AD, Reid IC, McDevitt DG, MacDonald TM. Association of road-traffic accidents with Benzodiazepine use. Lancet 1998; 353: 1331-1336
17. Currie D, Hashemi K, Fothergill J, Findlay A, Harris A, Hindmarch I. The use of antidepressants and benzodiazepines in the perpetrators and victims of accidents. Occup Med (Lond) 1995; 45: 323-325
18. Neutel CI. Risk of traffic accident injury after a prescription for a benzodiazepine. Ann Epidemiol 1995; 5: 239-244
19. Fortenberry JC, Brown DB, Shevlin LT. Analysis of drug involvement in traffic fatalities in Alabama. Am J Drug Alcohol Abuse 1986; 12: 257-267
20. Gjerde H, Beylich KM, Morland J. Incidence of alcohol and drugs in fatally injured car drivers in Norway. Accid Anal Prev 1993; 25: 479-483
21. Mercer GW, Jeffery WK. Alcohol, drugs, and impairment in fatal traffic accidents in British Columbia. Accid Anal Prev 1995; 27: 335-343
22. Druid H, Holmgren P, Ahlner J. Flunitrazepam: an evaluation of use, abuse and toxicity. Forensic Sci Int 2001; 122: 136-141
23. Honkanen R, Ertama L, Linnoila M, Alha A, Lukkaria I, Karlsson M, Kiviluoto O, Puro M. Role of drugs in traffic accidents. Br Med J 1980; 281: 1309-1312
24. Thomas RE. Benzodiazepine use and motor vehicle accidents: Systematic review of reported association. Can Fam Physican 1998; 44: 799-808
25. Bocca ML, Le Doze F, Etard O, Pottier M, L'Hoste J, Denise P. Residual effects of zolpidem 10 mg and zopiclone 7.5 mg versus flunitrazepam 1 mg and placebo on driving performance and ocular saccades. Psychopharmacology 1999; 143: 373-379
26. Gerhard U, Linnenbrink N, Georghiadou C, Hobi V. Vigilanzmindernde Effekte zweier pflanzlicher Schlafmittel. Schweizer Rundschau für Medizin (Praxis) 1996; 85: 473-481
27. Harrison C, Subhan Z, Hindmarch I. Residual effects of zopiclone and benzodiazepine hypnotics on psychomotor performance related to car driving. Drugs Exp Clin Res 1985; XI: 823-829
28. Vermeeren A, O'Hanlon JF, DeClerk AC, Kho L. Acute effects of zolpidem and flunitrazepam on sleep, memory and driving performance, compared to those of partial sleep deprivation and placebo. Acta Ther 1995; 21: 47-64
29. Hindmarch I. Psychomotor function and psychoactive drugs. Br J Clin Pharmacol 1980; 10: 189-209
30. Curran HV. Benzodiazepines, memory and mood: a review. Psychopharmacology 1991; 105: 1-8
31. Bond AJ, Lader MH. Residual effects of flunitrazepam. Br J Clin Pharmacol 1975; 2: 143-150
32. Saletu B, Grünberger J, Taeuber K, Nitsche V. Relation between pharmacodynamic and -kinetics: EEG and psychometric studies with cinolazepam and nomifensine. In: Hermann. EEG in Drug Research. Stuttgart, New York: Gustav Fischer, 1982: 89-111
33. Griffiths AN, Marshall RW, Richens A. Saccadic eye movement analysis as a measure of drug effects on human performance. Br J Clin Pharmacol 1984; 18: 73S-82S
34. Staak M, Hobi V, Berghaus G. Testverfahren zur Überprüfung des Einflusses von Arzneimitteln auf die Verkehrssicherheit - Medizinischer Schwerpunkt. In: Dilling J, Friedel B. 8305/2,. Bergisch Gladbach, Bundesanstalt für Straßenwesen. Forschungsberichte der BASt - Unfallforschung. 1988: 1-195
35. Berghaus G. Persönliche Mitteilung. 1998
36. Kasper S, Volz HP. Psychiatrie compact. Stuttgart, New York: Georg Thieme Verlag, 2003
37. Allain H, Patat A, Lieury A, Le Coz F, Janus C, Ménard G, Gandon JM. Comparative study of the effects of zopiclone (7.5 mg), zolpidem, flunitrazepam and a placebo on nocturnal cognitive performance in healthy subjects, in relation to pharmacokinetics. Eur Psychiatry 1995; 10 (Suppl 3): 129s-135s
38. Bareggi SR, Ferini-Strambi L, Pirola R, Smirne S. Impairment of memory and plasma flunitrazepam levels. Psychopharmacology 1998; 140: 157-163
39. Ingum J, Bjørklund R, Bjørnboe A, Christophersen AS, Dahlin E, Mørland J. Relationship between drug plasma concentrations and psychomotor performance after single doses of ethanol and benzodiazepines. Psychopharmacology 1992; 107: 11-17
40. Smirne S, Ferini-Strambi L, Pirola R, Tancredi O, Franceschi M, Pinto P, Bareggi SR. Effects of flunitrazepam on cognitive functions. Psychopharmacology 1989; 98: 251-256
41. Wickstrom E, Godtlibsen OB. The effects of quazepam, triazolam, flunitrazepam and placebo, alone and in combination with ethanol, on day-time sleep, memory, mood and performance. Hum Psychopharmacol 1988; 3: 101-110
42. Linnoila M, Erwin CW, Brendle A, Logue P. Effects of alcohol and flunitrazepam on mood and performance in healthy young men. J Clin Pharmacol 1981; 21: 430-435
43. Kuhlmann J, Berger W, Podzuweit H, Schmidt U. The influence of valerian treatment on "reaction time, alertness and concentration" in volunteers. Pharrnacopsychiatry 1999; 32: 235-241
44. Schmidt U, Brendemühl D, Ruther E. Aspects of driving after hypnotic therapy with particular reference to temazepam. Acta Psychiatr Scand 1986; (Suppl 332): 112-118
45. Sicard BA, Trocherie S, Moreau J, Vieillefond H, Court LA. Evaluation of zolpidem on alertness and psychomotor abilities among aviation ground personnel and pilots. Aviat Space Environ Med 1993; 64: 371-375
46. Stanley RO, Tiller JWG, Adrian J. The psychomotor effects of single and repeated doses of hypnotic benzodiazepines. Int Clin Psychopharmacol 1987; 2: 317-323
47. Dujardin K, Guieu JD, Leconte-Lambert C, Leconte P, Borderies P, de La Giclais B. Comparison of the effects of zolpidem and flunitrazepam on sleep structure and daytime cognitive functions: A study of untreated unsomniacs. Pharmacopsychiatry 1998; 31: 14-18
48. Rettig HC, Zuurmond WWA, Leeuwen L van. Quality of sleep and psychomotor performance after lormetazepam or flunitrazepam: a randomized and double-blind study. J Drugtherapy Res 1988; 13: 141-144
49. Bensimon G, Foret J, Warot D, Lacomblez L, Thiercelin JF, Simon P. Day-time wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placebo. Br J Clin Pharmacol 1990; 30: 463-469
50. Mattmann P, Loepfe M, Scheitlin T, Schmidlin D, Gerne M, Strauch I, Lehmann D, Borbély AA. Day-time residual effects and motor activity after three benzodiazepine hypnotics. Arzneimittelforschung 1982; 32: 461-465
51. Ott H. Are electroencephalographic and psychomotor measures sensitive in detecting residual sequelae of benzodiazepine hypnotics? Psychopharmacology 1984; (Suppl 1): 133-151
52. Seppälä T, Nuotto E, Dreyfus JF. Drug-alcohol interactions on psychomotor skills: Zopiclone and Flunitrazepam. Pharmacology 1983; 27 (Suppl 2): 127-135
53. Short TG, Galletly DC. Acute tolerance from benzodiazepine night sedation. Anaesthesia 1991; 46: 929-931
54. Frattola L, Maggioni M, Cesana B, Priore P. Double blind comparison of zolpidem 20 mg versus flunitrazepam 2 mg in insomniac in-patients. Drugs Exp Clin Res 1990; XVI: 371-376
55. Hindmarch I. A repeated dose comparison of three benzodiazepine derivatives (nitrazepam, flurazepam and flunitrazepam) on subjective appraisals of sleep and measures of psychomotor performance the morning following night-time medication. Acta Psychiatr Scand 1977; 56: 373-381
56. Hindmarch I, Parrott AC, Arenillas L. A repeated dose comparison of dichloralphenazone, flunitrazepam and amylobarbitone sodium on some aspects of sleep and early morning behaviour in normal subjects. Br J Clin Pharmacol 1977; 4: 229-233
57. Hofferberth B. Saccadic eye movements as a measure of residual effects: temazepam compared with other hypnotics. Acta Psychiatr Scand 1986; 74 (Suppl. 332): 105-111
58. Lader M, Melhuish A, Harris P. Residual effects of repeated doses of 0.5 and 1 mg flunitrazepam. Eur J Clin Pharmacol 1982; 23: 135-140
59. Charlier CJ, Maes VA, Smet HC, Verrstraete A, Wennig R. Influence des médicaments sur les capacités de conduite - Etude de la littérature. In: van Den Meersschaut C. 1. Brussel, Institut Belge pour la Sécurité Routiére asbl. 1999 (IBSR)
60. Kaufmann RM. Medikamente und Fahrtüchtigkeit - Klassifizierung von Benzodiazepinderivaten nach pharmakologischen und verkehrsmedizinischen Gesichtspunkten. Dissertation, Institut für Gerichtliche Medizin der Leopold-Franzens-Universität Innsbruck. 2002: 1-220
61. Darcourt G, Pringuey D, Salliere D, Lavoisy J. The safety and tolerability of zolpidem - an update. J Psychopharmacol 1999; 13: 81-93
62. DeClerk AC, Bisserbe JC. Short-term safety profile of zolpidem: objective measures of cognitive effects. Eur Psychiatry 1997; 12 (Suppl 1): 15s-20s
63. Lader M, Hindmarch I. Memory, psychomotor and cognitive functions after treatment with zolpidem. In: Freeman H, Puech AJ, Roth T, eds.: Zolpidem an update of its pharmacological properties and therapeutic place in the management of insomnia. Paris: Elsevier, 1996: 59-71
64. Unden M, Roth Schlechter B. Next day effects after nighttime treatment with zolpidem: A review. Eur Psychiatry 1996; 11 (Suppl. 1): 21S-30S
65. Greenblatt DJ, Divoll M, Harmatz JS, Mac Laughlin DS, Shader RI. Kinetics and clinical effects of flurazepam in young and elderly noninsomniacs. Clin Pharmacol Ther 1981; 30: 475-486
66. Greenblatt DJ, Harmatz JS, Shapiro L, Engelhardt N, Gouthro TA, Shader MD. Sensitivity to triazolam in the elderly. N Engl J Med 1991; 324: 1691-1698
67. Ray WA, Thapa PB, Shorr RI. Medications and the older driver. Clin Geriatr Med 1993; 9: 413-438
68. Roth T, Ancoli-Israel S. Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II. Sleep 1999; Suppl 2: S354-S358
69. Ellinwood EH, Heatherly DG. Benzodiazepines, the popular tranquilizers: Dynamic of effect on driving skills. Accid Anal Prev 1985; 17: 283-290
70. Kunsman GW, Manno JE, Manno BR, Kunsman CM, Przekop MA. The use of microcomputer-based psychomotor tests for the evaluation of benzodiazepine effects on human performance: a review with emphasis on temazepam. Br J Clin Pharmacol 1992; 34: 289-301
71. Bramness JG, Skurtveit S, Mørland J. Clinical impairment of benzodiazepines-relation between benzodiazepine concentrations and impairment in apprehended drivers. Drug Alcohol Depend 2002; 68: 131-141
72. de Gier JJ. Driving tests with patients. Br J Clin Pharmacol 1984; 18: 103S-108S
73. Ramaekers JG, Veggel LM van, O'Hanlon JF. A cross-study of the effects of moclobemide and brofaromine on actual driving performance. Clin Neuropharmacol 1994; 17 (Suppl 1): S9-S18
74. Volkerts ER, Vries G de, Wiethof M, Meyer T, O'Hanlon JF. Loprazolam and flunitrazepam's residual effects upon actual driving performance. Technical Report VK 83-04. University of Groningen, Netherlands: Traffic Research Centre, 1983
75. Volkerts ER, Louwers JW, Gloerich ABM, Brookhuis KJ, O'Hanlon JF. Zopiclone's residual effects upon actual driving performance versus those of nitrazepam and flunitrazepam. Technical Report VK 84-10. University of Groningen, Netherlands: Traffic Research Centre, 1984
76. Irving A, Jones W. Methods for testing impairment of driving due to drugs. Eur J Clin Pharmacol 1992; 43: 61-66
77. Stone BI. Pencil and paper tests-sensitivity to psychotropic drugs. Br J Clin Pharmacol 1984; 18: 15S-20S
78. Hindmarch I, Ott H, Roth T. Sleep, benzodiazepines and performance. "Experimental Methodologies and Research Prospects". Heidelberg: Springer Verlag, 1984
79. Wittenborn JR, Flaherty CF, Hamilton LW, Schiffman RT, McGough WE. The effect of minor tranquilizers on psychomotor performance. Psychopharmacology 1976; 47: 281-286
80. Berghaus G, Staak M. Testverfahren zur Überprüfung des Einflusses von Arzneimitteleinnahme auf die Fahrsicherheit. Beitr Gerichtl Med 1988; 46: 67-70
81. Ferrara SD. Quality assurance and standardization of empirical trials on drugs and driving. Proceedings of the 12th international conference on alcohol, drugs and traffic safety. Köln, 1992.